Extra-pulmonary complications of 45 critically ill patients with COVID-19 in Yichang, Hubei province, China: A single-centered, retrospective, observation study
- PMID: 33655925
- PMCID: PMC7939178
- DOI: 10.1097/MD.0000000000024604
Extra-pulmonary complications of 45 critically ill patients with COVID-19 in Yichang, Hubei province, China: A single-centered, retrospective, observation study
Abstract
Mortality of critically ill patients with coronavirus disease 2019 (COVID-19) was high. Aims to examine whether time from symptoms onset to intensive care unit (ICU) admission affects incidence of extra-pulmonary complications and prognosis in order to provide a new insight for reducing the mortality. A single-centered, retrospective, observational study investigated 45 critically ill patients with COVID-19 hospitalized in ICU of The Third People's Hospital of Yichang from January 17 to March 29, 2020. Patients were divided into 2 groups according to time from symptoms onset to ICU admission (>7 and ≤7 days) and into 2 groups according to prognosis (survivors and non-survivors). Epidemiological, clinical, laboratory, radiological characteristics and treatment data were studied. Compared with patients who admitted to the ICU since symptoms onset ≤7 days (55.6%), patients who admitted to the ICU since symptoms onset >7 days (44.4%) were more likely to have extra-pulmonary complications (19 [95.0%] vs 16 [64.0%], P = .034), including acute kidney injury, cardiac injury, acute heart failure, liver dysfunction, gastrointestinal hemorrhage, hyperamylasemia, and hypernatremia. The incidence rates of acute respiratory distress syndrome, pneumothorax, and hospital-acquired pneumonia had no difference between the 2 groups. Except activated partial thromboplastin and Na+ concentration, the laboratory findings were worse in group of time from symptoms onset to ICU admission >7 days. There was no difference in mortality between the 2 groups. Of the 45 cases in the ICU, 19 (42.2%) were non-survivors, and 16 (35.6%) were with hospital-acquired pneumonia. Among these non-survivors, hospital-acquired pneumonia was up to 12 (63.2%) besides higher incidence of extra-pulmonary complications. However, hospital-acquired pneumonia occurred in only 4 (15.4%) survivors. Critically ill patients with COVID-19 who admitted to ICU at once might get benefit from intensive care via lower rate of extra-pulmonary complications.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
All the authors state that there are no conflicts of interest related to this study.
Figures


Similar articles
-
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24. Lancet Respir Med. 2020. PMID: 32105632 Free PMC article.
-
Complications of new-onset atrial fibrillation in critically ill COVID-19 patients admitted to the intensive care unit (ICU): a meta-analysis.BMC Cardiovasc Disord. 2024 Aug 5;24(1):407. doi: 10.1186/s12872-024-04086-5. BMC Cardiovasc Disord. 2024. PMID: 39103764 Free PMC article.
-
Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China.Crit Care. 2020 Jul 6;24(1):394. doi: 10.1186/s13054-020-03098-9. Crit Care. 2020. PMID: 32631393 Free PMC article.
-
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.Cochrane Database Syst Rev. 2020 May 14;5(5):CD013600. doi: 10.1002/14651858.CD013600. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2020 Jul 10;7:CD013600. doi: 10.1002/14651858.CD013600.pub2. PMID: 32406927 Free PMC article. Updated.
-
Implementation of post-intensive care outpatient clinic (I-POINT) for critically ill COVID-19 survivors.Turk J Med Sci. 2021 Dec 17;51(SI-1):3350-3358. doi: 10.3906/sag-2106-306. Turk J Med Sci. 2021. PMID: 34333907 Free PMC article. Review.
Cited by
-
Gastrointestinal Bleeding in COVID-19-Infected Patients.Gastroenterol Clin North Am. 2023 Mar;52(1):77-102. doi: 10.1016/j.gtc.2022.10.004. Epub 2022 Nov 1. Gastroenterol Clin North Am. 2023. PMID: 36813432 Free PMC article. Review.
-
An Imaging Overview of COVID-19 ARDS in ICU Patients and Its Complications: A Pictorial Review.Diagnostics (Basel). 2022 Mar 29;12(4):846. doi: 10.3390/diagnostics12040846. Diagnostics (Basel). 2022. PMID: 35453894 Free PMC article. Review.
-
Acute Kidney Injury and Renal Replacement Therapy in COVID-19 Versus Other Respiratory Viruses: A Systematic Review and Meta-Analysis.Can J Kidney Health Dis. 2021 Oct 30;8:20543581211052185. doi: 10.1177/20543581211052185. eCollection 2021. Can J Kidney Health Dis. 2021. PMID: 34733538 Free PMC article.
-
Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis.Crit Care Med. 2021 Dec 1;49(12):2042-2057. doi: 10.1097/CCM.0000000000005195. Crit Care Med. 2021. PMID: 34259663 Free PMC article.
References
-
- Mu A. A COVID-19 transmission within a family cluster by presymptomatic infectors in China. J Chem Inf Model 2019;53:1689–99.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical